1. Kevin Outterson ( ) is a professor at the School of Law, Boston University, in Massachusetts, and an associate fellow at the Royal Institute of International Affairs at Chatham House, in London, England, where he coordinates a working group on new business models for antibiotics. He is also a member of the Centers for Disease Control and Prevention’s Antimicrobial Resistance Working Group, in Atlanta, Georgia.
2. John H. Powers is an associate clinical professor of medicine at the George Washington University School of Medicine, in Washington, D.C.
3. Gregory W. Daniel is managing director for evidence development and innovation at the Engelberg Center for Health Care Reform at Brookings, in Washington, D.C.
4. Mark B. McClellan is a senior fellow and director of the Health Care Innovation and Value Initiative at the Engelberg Center for Health Care Reform at Brookings.